112 related articles for article (PubMed ID: 10982118)
1. Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting.
Andrade SE; Gurwitz JH; Cernieux J; Fish LS
Med Care; 2000 Sep; 38(9):970-5. PubMed ID: 10982118
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic interchange of conjugated and esterified estrogens in a managed care organization.
Baluch WM; Gardner JS; Krauss RH; Scholes D
Am J Health Syst Pharm; 1999 Mar; 56(6):537-42. PubMed ID: 10192688
[TBL] [Abstract][Full Text] [Related]
3. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
[TBL] [Abstract][Full Text] [Related]
4. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
5. [Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico].
Velasco-Murillo V
Gac Med Mex; 2001; 137(3):237-42. PubMed ID: 11432092
[TBL] [Abstract][Full Text] [Related]
6. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of a substitution of estrogen replacement therapy to women enrolled in a health maintenance organization.
Gardner J; Scholes D; Baluch W; Krauss R
J Womens Health; 1998 Oct; 7(8):1027-31. PubMed ID: 9812299
[TBL] [Abstract][Full Text] [Related]
8. Preliminary observations on differing psychological effects of conjugated and esterified estrogen treatments.
Friebely JS; Shifren JL; Schiff I; Regestein QR
J Womens Health Gend Based Med; 2001 Mar; 10(2):181-7. PubMed ID: 11268301
[TBL] [Abstract][Full Text] [Related]
9. Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke.
Lemaitre RN; Weiss NS; Smith NL; Psaty BM; Lumley T; Larson EB; Heckbert SR
Arch Intern Med; 2006 Feb; 166(4):399-404. PubMed ID: 16505258
[TBL] [Abstract][Full Text] [Related]
10. Decline in incidence of endometrial cancer following increase in prescriptions for opposed conjugated estrogens in a prepaid health plan.
Ziel HK; Finkle WD; Greenland S
Gynecol Oncol; 1998 Mar; 68(3):253-5. PubMed ID: 9570976
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and colon cancer among members of a health maintenance organization.
Jacobs EJ; White E; Weiss NS; Heckbert SR; LaCroix A; Barlow WE
Epidemiology; 1999 Jul; 10(4):445-51. PubMed ID: 10401882
[TBL] [Abstract][Full Text] [Related]
12. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
[TBL] [Abstract][Full Text] [Related]
13. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
14. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.
Majumdar SR; Almasi EA; Stafford RS
JAMA; 2004 Oct; 292(16):1983-8. PubMed ID: 15507584
[TBL] [Abstract][Full Text] [Related]
15. The WHI estrogen-alone trial--do things look any better?
Hulley SB; Grady D
JAMA; 2004 Apr; 291(14):1769-71. PubMed ID: 15082705
[No Abstract] [Full Text] [Related]
16. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
Nelson HD
JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049
[TBL] [Abstract][Full Text] [Related]
17. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term estrogen replacement therapy. II. Neoplasia.
Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and efficacy of different estrogens are not equivalent.
Ansbacher R
Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
[TBL] [Abstract][Full Text] [Related]
20. Estrogen therapy for severe persistent depressions in women.
Klaiber EL; Broverman DM; Vogel W; Kobayashi Y
Arch Gen Psychiatry; 1979 May; 36(5):550-4. PubMed ID: 219802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
